isatin has been researched along with fluorouracil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abutaha, N; El-Faham, A; Farooq, M; Fun, HK; Ghabbour, HA; Khattab, SN; Wadaan, MA | 1 |
| Abdel-Samii, ZKM; Abdelnaser, A; Al-Mahmoudy, AMM; Bekheit, MS; Fayad, W; Girgis, AS; Ibrahim, TS; Nasr, S; Panda, SS; Said, MF; Sakhuja, R; Seliem, IA; Soliman, AAF; Tran, QL | 1 |
2 other study(ies) available for isatin and fluorouracil
| Article | Year |
|---|---|
Synthesis, Characterization, and Anti-Cancer Activity of Some New N'-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; HEK293 Cells; Hep G2 Cells; Humans; Hydrazones; Isatin; Jurkat Cells; Valproic Acid | 2015 |
Development of Isatin-Based Schiff Bases Targeting VEGFR-2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies.
Topics: Antineoplastic Agents; Fluorouracil; Humans; Isatin; Quantitative Structure-Activity Relationship; Schiff Bases; Sunitinib; Vascular Endothelial Growth Factor Receptor-2 | 2022 |